Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. KNX
10. IBM

Go back to Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Audentes Therapeutics (BOLD) Misses Q3 EPS by 9c

November 6, 2018 4:46 PM EST

Audentes Therapeutics (NASDAQ: BOLD) reported Q3 EPS of ($0.97), $0.09 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $0 , versus $0 reported last year.

As of September 30, 2018, we had cash, cash equivalents, marketable securities and restricted cash of $285.5 million, which includes approximately $3.6 million... More